NGC Update Service: July 1, 2013

July 1, 2013

---

New This Week

Expert Commentary NGC and NQMC Survey Responses Generate Enhancement and Growth By: the National Guideline Clearinghouse and National Quality Measures Clearinghouse Teams Guideline Summaries American College of Radiology ACR Appropriateness Criteria® abdominal aortic aneurysm: interventional planning and follow-up. This updates a previously published guideline summary. ACR Appropriateness Criteria® nonpalpable mammographic findings (excluding calcifications). This updates a previously published guideline summary. ACR Appropriateness Criteria® palpable breast masses. This updates a previously published guideline summary. ACR Appropriateness Criteria® radiologic management of inferior vena cava filters. This updates a previously published guideline summary. American Congress of Rehabilitation Medicine New Developer Assessment scales for disorders of consciousness: evidence-based recommendations for clinical practice and research. Centers for Disease Control and Prevention Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. Program in Evidence-based Care Stem cell transplantation in lymphoma. Society of Critical Care Medicine Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. This updates a previously published guideline summary.

Announcements

New Features on NGC

• Visit the Advanced Search page to filter search results by U.S.-based developers.
• See which guideline summaries are included in guideline syntheses via the By Organization browse.

Revised Inclusion Criteria

NGC has completed the process of revising its Inclusion Criteria! Visit our updated Inclusion Criteria page to see the new criteria and send us your comments.

Conference News

• The Guidelines International Network North America (G-I-N NA) continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, is available on the G-I-N Web site.

U.S. Food and Drug Administration (FDA) Advisories

• June 24, 2013: Hydroxyethyl Starch Solutions: FDA has concluded that HES solutions should not be used in critically ill adult patients, including patients with sepsis and those admitted to the ICU, and a Boxed Warning to include the risk of mortality and severe renal injury is warranted. In addition, FDA has reviewed a meta-analysis of studies conducted in patients undergoing open heart surgery in association with cardiopulmonary bypass and has determined that an additional warning about excessive bleeding is needed in the Warnings and Precautions Section of the package insert.
• June 18, 2013: Zyprexa Relprevv (Olanzapine Pamoate): FDA is investigating two unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv (olanzapine pamoate). The patients died 3-4 days after receiving an appropriate dose of the drug, well after the 3-hour post-injection monitoring period required under the Zyprexa Relprevv Risk Evaluation and Mitigation Strategy (REMS). FDA is providing this information to health care professionals while it continues its investigation.

NGC's Sister Resources

• Find Innovations and QualityTools classified by disease or clinical category, patient population, setting of care, stage of care, and more in AHRQ's Health Care Innovations Exchange Web site.
• Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC).

---

   How satisfied are you with this e-mail bulletin? Give Us Your Feedback